Quantitative	O
evaluation	O
of	O
the	O
strategy	O
to	O
eliminate	O
human	B-DS
African	I-DS
trypanosomiasis	I-DS
in	O
the	O
Democratic	O
Republic	O
of	O
Congo	O

Background	O

The	O
virulent	O
vector	B-DS
-	I-DS
borne	I-DS
disease	I-DS
,	O
Gambian	O
human	B-DS
African	I-DS
trypanosomiasis	I-DS
(	O
HAT	B-DS
),	O
is	O
one	O
of	O
several	O
diseases	O
targeted	O
for	O
elimination	O
by	O
the	O
World	O
Health	O
Organization	O
.	O

This	O
article	O
utilises	O
human	B-OG
case	O
data	O
from	O
a	O
high	O
-	O
endemicity	O
region	O
of	O
the	O
Democratic	O
Republic	O
of	O
Congo	O
in	O
conjunction	O
with	O
a	O
suite	O
of	O
novel	O
mechanistic	O
mathematical	O
models	O
to	O
address	O
the	O
effectiveness	O
of	O
on	O
-	O
going	O
active	O
screening	O
and	O
treatment	O
programmes	O
and	O
compute	O
the	O
likely	O
time	O
to	O
elimination	O
as	O
a	O
public	O
health	O
problem	O
(	O
i	O
.	O
e	O
.	O
<	O
1	O
case	O
per	O
10	O
,	O
000	O
per	O
year	O
).	O

Methods	O

The	O
model	O
variants	O
address	O
uncertainties	O
surrounding	O
transmission	O
of	O
HAT	B-DS
infection	I-DS
including	O
heterogeneous	O
risk	O
of	O
exposure	O
to	O
tsetse	B-OG
bites	O
,	O
non	O
-	O
participation	O
of	O
certain	O
groups	O
during	O
active	O
screening	O
campaigns	O
and	O
potential	O
animal	B-OG
reservoirs	O
of	O
infection	B-DS
.	O

Results	O

Model	O
fitting	O
indicates	O
that	O
variation	O
in	O
human	B-OG
risk	O
of	O
tsetse	B-OG
bites	O
and	O
participation	O
in	O
active	O
screening	O
play	O
a	O
key	O
role	O
in	O
transmission	O
of	O
this	O
disease	O
,	O
whilst	O
the	O
existence	O
of	O
animal	B-OG
reservoirs	O
remains	O
unclear	O
.	O

Active	O
screening	O
campaigns	O
in	O
this	O
region	O
are	O
calculated	O
to	O
have	O
been	O
effective	O
,	O
reducing	O
the	O
incidence	O
of	O
new	O
human	B-OG
infections	B-DS
by	O
52	O
–	O
53	O
%	O
over	O
a	O
15	O
-	O
year	O
period	O
(	O
1998	O
–	O
2012	O
).	O

However	O
,	O
projections	O
of	O
disease	O
dynamics	O
in	O
this	O
region	O
indicate	O
that	O
the	O
elimination	O
goal	O
may	O
not	O
be	O
met	O
until	O
later	O
this	O
century	O
(	O
2059	O
–	O
2092	O
)	O
under	O
the	O
current	O
intervention	O
strategy	O
.	O

Conclusions	O

Improvements	O
to	O
active	O
detection	O
,	O
such	O
as	O
screening	O
those	O
who	O
have	O
not	O
previously	O
participated	O
and	O
raising	O
overall	O
screening	O
levels	O
,	O
as	O
well	O
as	O
beginning	O
widespread	O
vector	O
control	O
in	O
the	O
area	O
have	O
the	O
potential	O
to	O
ensure	O
successful	O
and	O
timely	O
elimination	O
.	O

Electronic	O
supplementary	O
material	O

The	O
online	O
version	O
of	O
this	O
article	O
(	O
doi	O
:	O
10	O
.	O
1186	O
/	O
s13071	O
-	O
015	O
-	O
1131	O
-	O
8	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

Background	O

The	O
London	O
Declaration	O
on	O
Neglected	O
Tropical	B-DS
Diseases	I-DS
[	O
1	O
,	O
2	O
]	O
lists	O
human	B-DS
African	I-DS
trypanosomiasis	I-DS
(	O
HAT	B-DS
)	O
as	O
one	O
of	O
the	O
diseases	O
targeted	O
for	O
“	O
elimination	O
”.	O

In	O
the	O
case	O
of	O
HAT	B-DS
,	O
the	O
elimination	O
target	O
is	O
defined	O
as	O
“	O
the	O
reduction	O
of	O
gambiense	O
HAT	B-DS
incidence	O
to	O
less	O
than	O
1	O
new	O
case	O
per	O
10	O
,	O
000	O
population	O
at	O
risk	O
,	O
in	O
at	O
least	O
90	O
%	O
of	O
foci	O
with	O
fewer	O
than	O
2000	O
cases	O
reported	O
globally	O
”	O
by	O
2020	O
and	O
“	O
to	O
target	O
zero	O
incidence	O
of	O
the	O
disease	O
by	O
2030	O
”	O
[	O
3	O
].	O

HAT	B-DS
is	O
caused	O
by	O
subspecies	O
of	O
Trypanosoma	B-OG
brucei	I-OG
,	O
a	O
protozoan	O
parasite	O
transmitted	O
by	O
tsetse	B-OG
flies	I-OG
(	O
Glossina	B-OG
spp	I-OG
.).	O

While	O
the	O
single	O
name	O
“	O
sleeping	B-DS
sickness	I-DS
”	O
is	O
commonly	O
used	O
,	O
the	O
disease	O
exists	O
in	O
two	O
distinct	O
forms	O
.	O

Most	O
(>	O
98	O
%)	O
cases	O
occur	O
in	O
West	O
and	O
Central	O
Africa	O
and	O
are	O
caused	O
by	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
gambiense	I-OG
transmitted	O
by	O
the	O
riverine	O
species	O
of	O
tsetse	B-OG
.	O

This	O
Gambian	O
form	O
of	O
the	O
disease	O
is	O
generally	O
regarded	O
as	O
an	O
anthroponosis	B-DS
[	O
4	O
],	O
although	O
parasites	O
are	O
sometimes	O
detected	O
in	O
non	O
-	O
human	B-OG
hosts	O
and	O
could	O
play	O
a	O
role	O
in	O
transmission	O
[	O
5	O
].	O

The	O
remaining	O
2	O
%	O
of	O
cases	O
are	O
caused	O
by	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
rhodesiense	I-OG
transmitted	O
by	O
savanna	O
species	O
of	O
tsetse	B-OG
.	O

Rhodesian	O
HAT	B-DS
is	O
a	O
zoonosis	B-DS
typically	O
associated	O
with	O
the	O
wilderness	O
areas	O
of	O
East	O
and	O
Southern	O
Africa	O
where	O
tsetse	B-OG
vectors	O
,	O
wild	O
reservoir	O
hosts	O
(	O
e	O
.	O
g	O
.,	O
warthog	B-OG
,	O
buffalo	B-OG
)	O
and	O
occasionally	O
cattle	B-OG
are	O
abundant	O
.	O

The	O
zoonotic	O
nature	O
of	O
Rhodesian	O
HAT	B-DS
means	O
that	O
complete	O
elimination	O
of	O
the	O
disease	O
is	O
unlikely	O
[	O
3	O
].	O

Hence	O
,	O
the	O
goal	O
of	O
elimination	O
is	O
specific	O
to	O
Gambian	O
HAT	B-DS
.	O

The	O
global	O
number	O
of	O
reported	O
cases	O
per	O
year	O
is	O
in	O
line	O
with	O
the	O
goal	O
of	O
elimination	O
.	O

WHO	O
’	O
s	O
target	O
is	O
for	O
a	O
steady	O
decline	O
to	O
2	O
,	O
000	O
cases	O
per	O
year	O
by	O
2020	O
:	O
the	O
target	O
for	O
2014	O
was	O
5	O
,	O
000	O
cases	O
[	O
6	O
]	O
compared	O
to	O
a	O
reported	O
number	O
of	O
3	O
,	O
679	O
[	O
7	O
].	O

The	O
last	O
bastion	O
of	O
Gambian	O
HAT	B-DS
is	O
the	O
Democratic	O
Republic	O
of	O
Congo	O
(	O
DRC	O
)	O
where	O
87	O
%	O
(	O
3	O
,	O
206	O
/	O
3	O
,	O
679	O
)	O
of	O
all	O
cases	O
reported	O
in	O
2014	O
occurred	O
.	O

The	O
results	O
for	O
2014	O
are	O
typical	O
for	O
the	O
last	O
15	O
years	O
(	O
2000	O
–	O
2014	O
):	O
cases	O
of	O
HAT	B-DS
from	O
the	O
DRC	O
have	O
been	O
between	O
58	O
%	O
(	O
11	O
,	O
481	O
/	O
19	O
,	O
963	O
in	O
2003	O
)	O
and	O
91	O
%	O
(	O
5	O
,	O
647	O
/	O
6	O
,	O
228	O
in	O
2013	O
)	O
of	O
all	O
cases	O
reported	O
globally	O
[	O
7	O
].	O

Within	O
DRC	O
itself	O
,	O
the	O
distribution	O
of	O
HAT	B-DS
is	O
also	O
highly	O
heterogeneous	O
with	O
three	O
provinces	O
being	O
particularly	O
important	O
.	O

Of	O
the	O
127	O
,	O
960	O
cases	O
reported	O
from	O
DRC	O
between	O
2000	O
and	O
2012	O
,	O
46	O
%	O
(	O
58	O
,	O
585	O
cases	O
)	O
came	O
from	O
Bandundu	O
province	O
,	O
21	O
%	O
(	O
26	O
,	O
692	O
cases	O
)	O
from	O
Kasaï	O
(	O
East	O
and	O
West	O
)	O
and	O
17	O
%	O
(	O
21	O
,	O
575	O
)	O
from	O
Équateur	O
[	O
8	O
].	O

Achieving	O
the	O
global	O
elimination	O
goal	O
for	O
Gambian	O
HAT	B-DS
therefore	O
depends	O
on	O
the	O
impact	O
of	O
interventions	O
in	O
the	O
DRC	O
and	O
these	O
three	O
provinces	O
in	O
particular	O
.	O

Control	O
of	O
Gambian	O
HAT	B-DS
in	O
DRC	O
,	O
as	O
elsewhere	O
,	O
has	O
depended	O
almost	O
exclusively	O
on	O
active	O
case	O
detection	O
and	O
treatment	O
[	O
9	O
].	O

In	O
the	O
DRC	O
for	O
instance	O
,	O
more	O
than	O
24	O
million	O
people	O
were	O
screened	O
between	O
2000	O
and	O
2012	O
[	O
8	O
].	O

As	O
HAT	B-DS
disease	O
progresses	O
through	O
two	O
distinct	O
stages	O
,	O
each	O
with	O
different	O
treatments	O
(	O
pentamindine	O
for	O
stage	O
1	O
and	O
nifurtimox	O
and	O
eflorithine	O
combination	O
treatment	O
(	O
NECT	O
)	O
for	O
stage	O
2	O
),	O
diagnosis	O
therefore	O
involves	O
the	O
use	O
of	O
multiple	O
diagnostic	O
tools	O
.	O

Diagnostic	O
algorithms	O
vary	O
across	O
space	O
and	O
time	O
,	O
however	O
key	O
steps	O
include	O
screening	O
for	O
infection	B-DS
usually	O
via	O
the	O
card	O
agglutination	O
test	O
for	O
trypanosomes	B-OG
performed	O
on	O
whole	O
blood	O
(	O
CATT	O
-	O
WB	O
),	O
visual	O
confirmation	O
of	O
the	O
parasite	O
using	O
microscopy	O
,	O
and	O
“	O
staging	O
”	O
disease	O
via	O
a	O
lumbar	O
puncture	O
;	O
if	O
more	O
than	O
5	O
white	O
cells	O
per	O
μ	O
l	O
(	O
microlitre	O
)	O
or	O
trypanosomes	B-OG
are	O
identified	O
in	O
cerebral	O
spinal	O
fluid	O
then	O
the	O
patient	O
has	O
stage	O
2	O
disease	O
[	O
9	O
].	O

In	O
addition	O
to	O
these	O
large	O
-	O
scale	O
active	O
programmes	O
,	O
some	O
individuals	O
self	O
-	O
present	O
at	O
medical	O
centres	O
following	O
onset	O
of	O
symptoms	O
of	O
which	O
the	O
worst	O
(	O
i	O
.	O
e	O
.	O
neurological	O
systems	O
)	O
occur	O
in	O
stage	O
2	O
;	O
this	O
is	O
referred	O
to	O
as	O
“	O
passive	O
”	O
detection	O
.	O

Historically	O
,	O
vector	O
control	O
has	O
not	O
played	O
an	O
important	O
role	O
because	O
of	O
the	O
cost	O
and	O
logistical	O
complexities	O
of	O
traditional	O
methods	O
of	O
tsetse	B-OG
control	O
[	O
10	O
]	O
and	O
the	O
emphasis	O
on	O
active	O
screening	O
continues	O
to	O
date	O
.	O

A	O
key	O
issue	O
is	O
whether	O
continuing	O
the	O
current	O
strategy	O
is	O
likely	O
to	O
result	O
in	O
the	O
elimination	O
of	O
Gambian	O
HAT	B-DS
in	O
the	O
DRC	O
.	O

To	O
address	O
this	O
question	O
we	O
have	O
developed	O
and	O
applied	O
a	O
mathematical	O
model	O
of	O
HAT	B-DS
to	O
data	O
from	O
Yasa	O
-	O
Bonga	O
and	O
Mosango	O
Districts	O
in	O
the	O
Bandundu	O
Province	O
of	O
DRC	O
.	O

The	O
use	O
of	O
models	O
to	O
analyse	O
vector	B-DS
-	I-DS
borne	I-DS
diseases	I-DS
originates	O
with	O
the	O
Ross	O
-	O
Macdonald	O
equation	O
for	O
malaria	B-DS
[	O
11	O
–	O
14	O
]	O
and	O
developments	O
of	O
this	O
model	O
have	O
formed	O
the	O
basis	O
of	O
several	O
models	O
of	O
HAT	B-DS
(	O
see	O
review	O
by	O
[	O
15	O
]).	O

Models	O
of	O
HAT	B-DS
differ	O
from	O
those	O
of	O
malaria	B-DS
in	O
two	O
important	O
respects	O
reflecting	O
differences	O
in	O
the	O
underlying	O
biology	O
of	O
the	O
two	O
diseases	O
.	O

First	O
,	O
tsetse	B-OG
flies	I-OG
are	O
susceptible	O
to	O
infection	B-DS
with	O
T	B-OG
.	I-OG
brucei	I-OG
sspp	I-OG
.	O
when	O
they	O
take	O
their	O
first	O
blood	O
from	O
an	O
infected	O
host	O
but	O
are	O
much	O
less	O
susceptible	O
for	O
subsequent	O
blood	O
-	O
meals	O
.	O

Indeed	O
some	O
models	O
assume	O
that	O
tsetse	B-OG
are	O
susceptible	O
at	O
their	O
first	O
feed	O
only	O
and	O
completely	O
refractory	O
thereafter	O
[	O
16	O
,	O
17	O
].	O

Some	O
studies	O
have	O
shown	O
that	O
older	O
flies	B-OG
can	O
be	O
infected	O
and	O
go	O
on	O
to	O
develop	O
mature	O
infections	B-DS
but	O
the	O
extent	O
of	O
this	O
feature	O
in	O
nature	O
is	O
uncertain	O
[	O
18	O
].	O

There	O
is	O
however	O
widespread	O
agreement	O
that	O
there	O
is	O
a	O
marked	O
“	O
teneral	O
phenomenon	O
”	O
whereby	O
susceptibility	O
declines	O
with	O
the	O
fly	B-OG
’	O
s	O
age	O
[	O
19	O
].	O

Second	O
,	O
it	O
is	O
generally	O
assumed	O
that	O
humans	B-OG
are	O
the	O
only	O
host	O
for	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
gambiense	I-OG
.	O

Again	O
empirical	O
data	O
suggest	O
that	O
this	O
might	O
not	O
always	O
be	O
the	O
case	O
:	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
gambiense	I-OG
has	O
been	O
detected	O
in	O
wildlife	O
[	O
20	O
]	O
and	O
livestock	O
[	O
21	O
,	O
22	O
]	O
and	O
experimental	O
infections	B-DS
with	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
gambiense	I-OG
have	O
shown	O
that	O
they	O
retain	O
their	O
pathogenicity	O
to	O
humans	B-OG
even	O
after	O
repeated	O
passage	O
through	O
pigs	B-OG
[	O
23	O
–	O
25	O
].	O

The	O
epidemiological	O
significance	O
of	O
these	O
empirical	O
data	O
is	O
uncertain	O
,	O
but	O
previous	O
modelling	O
has	O
suggested	O
that	O
it	O
is	O
possible	O
that	O
such	O
infected	O
animals	B-OG
may	O
be	O
an	O
important	O
reservoir	O
of	O
infection	B-DS
[	O
5	O
].	O

Hence	O
the	O
teneral	O
phenomenon	O
and	O
the	O
potential	O
for	O
non	O
-	O
humans	B-OG
to	O
act	O
as	O
hosts	O
for	O
trypanosomes	B-OG
need	O
to	O
be	O
incorporated	O
into	O
models	O
of	O
HAT	B-DS
.	O

Model	O
predictions	O
for	O
the	O
impact	O
of	O
active	O
screening	O
on	O
the	O
incidence	O
of	O
HAT	B-DS
are	O
dependent	O
on	O
key	O
assumptions	O
regarding	O
the	O
heterogeneity	O
of	O
the	O
human	B-OG
population	O
in	O
relation	O
to	O
(	O
i	O
)	O
their	O
exposure	O
to	O
infection	B-DS
and	O
(	O
ii	O
)	O
their	O
willingness	O
to	O
be	O
screened	O
.	O

It	O
is	O
widely	O
recognised	O
that	O
some	O
groups	O
of	O
people	O
are	O
more	O
likely	O
to	O
be	O
bitten	O
than	O
others	O
.	O

For	O
instance	O
,	O
it	O
is	O
self	O
-	O
evident	O
that	O
people	O
with	O
occupations	O
that	O
require	O
them	O
to	O
spend	O
extended	O
periods	O
in	O
riverine	O
habitats	O
(	O
e	O
.	O
g	O
.,	O
fishermen	O
,	O
women	B-OG
carrying	O
out	O
domestic	O
chores	O
such	O
as	O
washing	O
and	O
collecting	O
water	O
)	O
are	O
more	O
likely	O
to	O
be	O
bitten	O
than	O
those	O
who	O
never	O
enter	O
such	O
tsetse	B-OG
-	O
infested	O
habitats	O
.	O

Screening	O
of	O
local	O
populations	O
seldom	O
exceeds	O
70	O
%	O
despite	O
efforts	O
to	O
mobilize	O
and	O
encourage	O
the	O
population	O
to	O
attend	O
[	O
26	O
,	O
27	O
]	O
and	O
there	O
are	O
strong	O
indications	O
that	O
some	O
groups	O
(	O
e	O
.	O
g	O
.	O
working	O
adults	O
)	O
are	O
consistently	O
under	O
represented	O
[	O
27	O
].	O

While	O
these	O
observations	O
suggest	O
that	O
there	O
are	O
strong	O
heterogeneities	O
in	O
the	O
human	B-OG
population	O
,	O
the	O
extent	O
of	O
this	O
is	O
not	O
well	O
quantified	O
and	O
likely	O
to	O
vary	O
between	O
settings	O
.	O

Our	O
understanding	O
of	O
the	O
biology	O
,	O
behaviour	O
and	O
ecology	O
of	O
some	O
species	O
of	O
tsetse	B-OG
is	O
relatively	O
good	O
[	O
4	O
,	O
28	O
].	O

However	O
,	O
the	O
important	O
vector	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
gambiense	I-OG
in	O
Yasa	O
Bonga	O
and	O
Mosango	O
is	O
G	B-OG
.	I-OG
fuscipes	I-OG
quanzensis	I-OG
and	O
for	O
this	O
species	O
there	O
are	O
scant	O
empirical	O
data	O
.	O

Some	O
aspects	O
of	O
the	O
basic	O
biology	O
of	O
all	O
species	O
of	O
tsetse	B-OG
are	O
very	O
similar	O
(	O
e	O
.	O
g	O
.	O
producing	O
a	O
single	O
offspring	O
at	O
~	O
9	O
day	O
intervals	O
,	O
both	O
sexes	O
taking	O
bloodmeals	O
at	O
~	O
3	O
day	O
intervals	O
)	O
and	O
we	O
can	O
be	O
reasonably	O
confident	O
in	O
applying	O
general	O
values	O
derived	O
from	O
one	O
closely	O
related	O
species	O
(	O
e	O
.	O
g	O
.	O
G	B-OG
.	I-OG
f	I-OG
.	I-OG
fuscipes	I-OG
)	O
to	O
provide	O
parameter	O
estimates	O
such	O
as	O
the	O
underlying	O
daily	O
mortality	O
and	O
feeding	O
interval	O
of	O
G	B-OG
.	I-OG
f	I-OG
.	I-OG
quanzensis	I-OG
.	O

On	O
the	O
other	O
hand	O
,	O
there	O
are	O
some	O
values	O
that	O
apply	O
to	O
G	B-OG
.	I-OG
f	I-OG
.	I-OG
quanzensis	I-OG
for	O
which	O
there	O
is	O
much	O
less	O
certainty	O
and	O
these	O
need	O
to	O
be	O
inferred	O
during	O
model	O
fitting	O
to	O
data	O
:	O
e	O
.	O
g	O
.	O
the	O
transmission	O
efficiencies	O
of	O
trypanosomes	B-OG
between	O
tsetse	B-OG
and	O
humans	B-OG
and	O
the	O
ratio	O
of	O
vectors	O
to	O
humans	B-OG
.	O

Robust	O
mathematical	O
models	O
,	O
in	O
conjunction	O
with	O
rigorous	O
statistical	O
fitting	O
to	O
available	O
data	O
are	O
fundamental	O
tools	O
for	O
modern	O
public	O
-	O
health	O
decision	O
makers	O
in	O
many	O
counties	O
[	O
29	O
–	O
32	O
].	O

Until	O
recently	O
,	O
this	O
approach	O
has	O
had	O
limited	O
impact	O
on	O
health	O
policy	O
in	O
impact	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
and	O
has	O
been	O
largely	O
overlooked	O
in	O
the	O
study	O
of	O
NTDs	O
(	O
although	O
onchocerciasis	B-DS
[	O
33	O
]	O
is	O
a	O
notable	O
exception	O
).	O

The	O
basic	O
principles	O
are	O
to	O
(	O
i	O
)	O
develop	O
a	O
mechanistic	O
mathematical	O
framework	O
that	O
captures	O
the	O
salient	O
aspects	O
of	O
known	O
biology	O
and	O
epidemiology	O
,	O
(	O
ii	O
)	O
match	O
this	O
model	O
to	O
available	O
data	O
,	O
and	O
(	O
iii	O
)	O
use	O
the	O
model	O
to	O
predict	O
forwards	O
in	O
time	O
allowing	O
multiple	O
control	O
options	O
to	O
be	O
investigated	O
.	O

Here	O
we	O
apply	O
these	O
concepts	O
to	O
HAT	B-DS
in	O
the	O
DRC	O
,	O
to	O
investigate	O
the	O
potential	O
of	O
current	O
controls	O
to	O
achieve	O
the	O
WHO	O
2020	O
goals	O
–	O
elimination	O
of	O
HAT	B-DS
as	O
a	O
public	O
health	O
problem	O
(	O
less	O
than	O
one	O
case	O
per	O
ten	O
thousand	O
per	O
year	O
)	O
by	O
2020	O
.	O

Many	O
epidemiologists	O
are	O
familiar	O
with	O
statistical	O
models	O
,	O
and	O
the	O
methods	O
surrounding	O
matching	O
such	O
models	O
to	O
data	O
.	O

Mechanistic	O
mathematical	O
models	O
are	O
simply	O
another	O
type	O
of	O
statistical	O
model	O
,	O
but	O
one	O
in	O
which	O
our	O
knowledge	O
and	O
assumptions	O
about	O
the	O
underlying	O
processes	O
are	O
explicitly	O
formulated	O
.	O

This	O
has	O
two	O
profound	O
implications	O
;	O
the	O
first	O
is	O
that	O
in	O
matching	O
models	O
and	O
data	O
the	O
parameter	O
values	O
inferred	O
generally	O
relate	O
to	O
specific	O
physical	O
quantities	O
such	O
as	O
average	O
infectious	O
periods	O
or	O
rates	O
of	O
transmission	O
.	O

The	O
second	O
is	O
that	O
when	O
using	O
the	O
model	O
to	O
extrapolate	O
forwards	O
in	O
time	O
,	O
it	O
is	O
possible	O
to	O
change	O
some	O
of	O
these	O
fundamental	O
parameters	O
and	O
hence	O
mimic	O
the	O
effects	O
of	O
control	O
mechanisms	O
.	O

Like	O
any	O
statistical	O
fitting	O
and	O
extrapolation	O
,	O
different	O
models	O
may	O
produce	O
different	O
results	O
–	O
just	O
as	O
fitting	O
linear	O
and	O
non	O
-	O
linear	O
statistical	O
models	O
can	O
generate	O
very	O
different	O
conclusions	O
.	O

Given	O
that	O
there	O
is	O
no	O
right	O
model	O
that	O
can	O
capture	O
every	O
element	O
of	O
the	O
transmission	O
process	O
,	O
and	O
since	O
many	O
of	O
the	O
mechanisms	O
are	O
unknown	O
for	O
HAT	B-DS
,	O
it	O
is	O
vitally	O
important	O
that	O
multiple	O
modelling	O
assumptions	O
are	O
tested	O
against	O
the	O
available	O
data	O
.	O

In	O
this	O
article	O
,	O
a	O
range	O
of	O
hypotheses	O
are	O
tested	O
utilising	O
data	O
from	O
a	O
HAT	B-DS
-	O
endemic	O
region	O
of	O
the	O
DRC	O
in	O
conjunction	O
with	O
mathematical	O
models	O
that	O
can	O
capture	O
different	O
assumptions	O
about	O
tsetse	B-OG
biology	O
and	O
behaviour	O
,	O
population	O
level	O
heterogeneities	O
,	O
and	O
the	O
potential	O
existence	O
of	O
animal	B-OG
reservoirs	O
.	O

Under	O
each	O
scenario	O
,	O
disease	O
dynamics	O
are	O
projected	O
forwards	O
to	O
determine	O
the	O
likely	O
time	O
to	O
elimination	O
as	O
a	O
public	O
health	O
problem	O
and	O
if	O
this	O
2020	O
goal	O
can	O
be	O
met	O
for	O
HAT	B-DS
.	O

Methods	O

Data	O

Bandundu	O
province	O
accounted	O
for	O
almost	O
half	O
of	O
the	O
reported	O
HAT	B-DS
cases	O
in	O
the	O
DRC	O
between	O
2000	O
–	O
2012	O
.	O

For	O
this	O
reason	O
the	O
region	O
is	O
of	O
great	O
interest	O
when	O
considering	O
elimination	O
goals	O
.	O

For	O
the	O
purposes	O
of	O
public	O
health	O
services	O
,	O
provinces	O
of	O
the	O
DRC	O
are	O
partitioned	O
into	O
smaller	O
administrative	O
units	O
known	O
as	O
“	O
Zones	O
de	O
Santé	O
”	O
or	O
health	O
zones	O
.	O

Two	O
health	O
zones	O
within	O
Bandundu	O
,	O
Yasa	O
-	O
Bonga	O
and	O
Mosango	O
,	O
with	O
a	O
combined	O
population	O
of	O
291	O
,	O
567	O
[	O
34	O
,	O
35	O
]	O
are	O
considered	O
in	O
this	O
article	O
.	O

The	O
WHO	O
Atlas	O
data	O
for	O
these	O
health	O
zones	O
cover	O
the	O
years	O
2000	O
–	O
2012	O
and	O
detail	O
the	O
total	O
number	O
of	O
actively	O
and	O
passively	O
detected	O
cases	O
in	O
addition	O
to	O
the	O
number	O
of	O
people	O
actively	O
screened	O
across	O
these	O
areas	O
[	O
36	O
,	O
37	O
].	O

During	O
these	O
years	O
,	O
active	O
detection	O
and	O
treatment	O
formed	O
the	O
primary	O
component	O
of	O
HAT	B-DS
control	O
programmes	O
in	O
this	O
area	O
with	O
no	O
large	O
-	O
scale	O
vector	O
control	O
interventions	O
being	O
implemented	O
[	O
8	O
].	O

During	O
model	O
simulation	O
and	O
fitting	O
,	O
the	O
aggregate	O
data	O
from	O
across	O
both	O
the	O
health	O
zones	O
was	O
used	O
.	O

The	O
percentage	O
of	O
the	O
population	O
screened	O
was	O
taken	O
to	O
be	O
the	O
total	O
reported	O
number	O
screened	O
from	O
the	O
WHO	O
Atlas	O
relative	O
to	O
the	O
estimated	O
constant	O
population	O
size	O
for	O
the	O
combined	O
health	O
zones	O
.	O

From	O
this	O
,	O
the	O
reported	O
incidence	O
per	O
10	O
,	O
000	O
people	O
per	O
year	O
was	O
also	O
computed	O
and	O
shown	O
in	O
relation	O
to	O
the	O
WHO	O
2020	O
goal	O
of	O
elimination	O
as	O
a	O
public	O
health	O
problem	O
(	O
see	O
Fig	O
.	O
1	O
).	O
Fig	O
.	O
1The	O
top	O
figure	O
shows	O
the	O
total	O
level	O
of	O
screening	O
and	O
detection	O
in	O
the	O
Yasa	O
-	O
Bonga	O
and	O
Mosango	O
health	O
zones	O
between	O
2000	O
and	O
2012	O
.	O

The	O
bottom	O
figure	O
shows	O
the	O
annual	O
incidence	O
based	O
on	O
an	O
assumed	O
population	O
size	O
of	O
289	O
,	O
030	O
in	O
relation	O
to	O
the	O
WHO	O
2020	O
goal	O
of	O
elimination	O
as	O
a	O
public	O
health	O
problem	O
(	O
shown	O
in	O
green	O
)	O

Model	O
variants	O

A	O
mechanistic	O
,	O
compartmental	O
model	O
which	O
describes	O
the	O
infection	B-DS
dynamics	O
in	O
the	O
population	O
was	O
developed	O
(	O
see	O
Fig	O
.	O
2	O
and	O
full	O
equations	O
in	O
SI	O
Section	O
1	O
).	O

This	O
model	O
and	O
its	O
variants	O
are	O
based	O
on	O
a	O
Ross	O
-	O
Macdonald	O
-	O
type	O
formulation	O
[	O
11	O
–	O
14	O
]	O
with	O
infection	B-DS
stages	O
in	O
humans	B-OG
,	O
tsetse	B-OG
and	O
potentially	O
animals	B-OG
.	O

In	O
all	O
cases	O
the	O
tsetse	B-OG
population	O
was	O
partitioned	O
into	O
four	O
distinct	O
classes	O
:	O
teneral	O
(	O
unfed	O
)	O
flies	B-OG
,	O
SV	O
;	O
non	O
-	O
teneral	O
(	O
previously	O
fed	O
)	O
and	O
uninfected	O
flies	B-OG
,	O
GV	O
;	O
exposed	O
(	O
infected	O
but	O
non	O
-	O
infective	O
)	O
flies	B-OG
,	O
EV	O
;	O
and	O
infective	O
flies	B-OG
,	O
IV	O
.	O

As	O
described	O
previously	O
,	O
the	O
teneral	O
phenomenon	O
means	O
that	O
fed	O
tsetse	B-OG
are	O
less	O
susceptible	O
than	O
their	O
teneral	O
counterparts	O
and	O
so	O
the	O
force	O
of	O
infection	B-DS
towards	O
them	O
is	O
scaled	O
by	O
a	O
factor	O
ε	O
(<	O
1	O
).	O

The	O
model	O
incorporates	O
natural	O
disease	O
history	O
in	O
humans	B-OG
following	O
infection	B-DS
with	O
individuals	O
progressing	O
through	O
the	O
classes	O
:	O
susceptible	O
,	O
SH	O
;	O
exposed	O
,	O
EH	O
;	O
stage	O
1	O
infection	B-DS
,	O
I1H	O
;	O
stage	O
2	O
infection	B-DS
I2H	O
;	O
and	O
removed	O
(	O
hospitalised	O
or	O
resting	O
),	O
RH	O
.	O

Here	O
,	O
both	O
stage	O
1	O
and	O
2	O
of	O
the	O
disease	O
were	O
assumed	O
to	O
be	O
equally	O
infective	O
to	O
tsetse	B-OG
,	O
whereas	O
removed	O
individuals	O
were	O
not	O
available	O
for	O
blood	O
-	O
feeding	O
.	O

It	O
was	O
assumed	O
that	O
stage	O
2	O
cases	O
either	O
were	O
successfully	O
diagnosed	O
and	O
treated	O
,	O
suffered	O
disease	O
induced	O
mortality	O
(	O
and	O
were	O
subsequently	O
replaced	O
by	O
a	O
new	O
susceptible	O
in	O
the	O
population	O
)	O
or	O
died	O
due	O
to	O
unrelated	O
causes	O
(	O
natural	O
mortality	O
)	O
prior	O
to	O
treatment	O
;	O
consequently	O
all	O
compartments	O
only	O
contain	O
living	O
individuals	O
.	O

It	O
is	O
assumed	O
that	O
humans	B-OG
received	O
a	O
proportion	O
,	O
fH	O
,	O
of	O
all	O
bites	O
,	O
with	O
the	O
rest	O
taken	O
on	O
animals	B-OG
that	O
are	O
initially	O
assumed	O
not	O
to	O
contribute	O
to	O
disease	O
transmission	O
(	O
non	O
-	O
reservoir	O
).	O
Fig	O
.	O
2Multi	O
-	O
host	O
model	O
of	O
HAT	B-DS
with	O
various	O
host	O
groups	O
able	O
to	O
acquire	O
and	O
transmit	O
HAT	B-DS
infection	I-DS
(	O
humans	B-OG
and	O
reservoir	O
animals	B-OG
),	O
further	O
non	O
-	O
reservoir	O
animal	B-OG
species	O
(	O
others	O
)	O
and	O
tsetse	B-OG
.	O

Human	B-OG
hosts	O
follow	O
the	O
progression	O
which	O
includes	O
an	O
infectious	O
stage	O
1	O
disease	O
,	O
I	O
H1	O
,	O
infectious	O
stage	O
2	O
disease	O
,	O
I	O
H2	O
,	O
and	O
a	O
non	O
-	O
infectious	O
(	O
due	O
to	O
hospitalisation	O
)	O
disease	O
,	O
R	O
H	O
.	O

Unfed	O
tsetse	B-OG
are	O
susceptible	O
,	O
S	O
V	O
,	O
and	O
following	O
a	O
blood	O
-	O
meal	O
become	O
either	O
exposed	O
,	O
E	O
V	O
,	O
or	O
have	O
reduce	O
susceptibility	O
to	O
the	O
trypanosomes	B-OG
,	O
G	O
V	O
.	O

Tsetse	B-OG
select	O
their	O
blood	O
-	O
meal	O
from	O
one	O
of	O
the	O
host	O
species	O
.	O

Any	O
blood	O
-	O
meals	O
taken	O
upon	O
non	O
-	O
reservoir	O
hosts	O
do	O
not	O
result	O
in	O
infection	B-DS
.	O

The	O
transmission	O
of	O
infection	B-DS
between	O
humans	B-OG
/	O
tsetse	B-OG
and	O
reservoirs	O
/	O
tsetse	B-OG
is	O
shown	O
by	O
grey	O
paths	O
.	O

Additional	O
humans	B-OG
follow	O
the	O
same	O
progression	O
as	O
the	O
first	O
human	B-OG
type	O
but	O
may	O
receive	O
more	O
bites	O
(	O
high	O
-	O
risk	O
)	O
or	O
may	O
not	O
participate	O
in	O
screening	O
.	O

Transmission	O
from	O
additional	O
humans	B-OG
to	O
tsetse	B-OG
is	O
not	O
shown	O
here	O
but	O
occurs	O
in	O
the	O
same	O
way	O
as	O
humans	B-OG
to	O
tsetse	B-OG

There	O
are	O
7	O
model	O
frameworks	O
investigated	O
to	O
analyse	O
competing	O
hypotheses	O
:	O

The	O
simple	O
model	O
:	O
Homogeneous	O
human	B-OG
risk	O
and	O
behaviour	O
model	O
.	O

This	O
model	O
used	O
the	O
standard	O
assumption	O
of	O
solely	O
anthroponotic	O
disease	O
transmission	O
and	O
,	O
due	O
to	O
its	O
simple	O
formulation	O
,	O
provided	O
a	O
suitable	O
framework	O
in	O
which	O
to	O
investigate	O
the	O
impact	O
of	O
teneral	O
susceptibility	O
and	O
other	O
fundamental	O
parameters	O
.	O

Models	O
for	O
heterogeneous	O
human	B-OG
populations	O
:	O
2	O
.	O
High	O
/	O
low	O
-	O
risk	O
populations	O
.	O

High	O
-	O
risk	O
individuals	O
being	O
more	O
exposed	O
to	O
tsetse	B-OG
bites	O
.	O
3	O
.	O
Random	O
participation	O
/	O
non	O
-	O
participation	O
.	O

A	O
fraction	O
of	O
the	O
population	O
never	O
participates	O
in	O
active	O
screening	O
,	O
while	O
the	O
remainder	O
randomly	O
participate	O
based	O
on	O
observed	O
screening	O
levels	O
.	O
4	O
.	O
High	O
-	O
risk	O
and	O
non	O
-	O
participation	O
/	O
low	O
-	O
risk	O
and	O
random	O
participation	O
.	O

High	O
-	O
risk	O
individuals	O
are	O
precisely	O
the	O
ones	O
who	O
never	O
participate	O
in	O
active	O
screening5	O
.	O
All	O
combinations	O
of	O
high	O
/	O
low	O
risk	O
and	O
random	O
/	O
non	O
-	O
participation	O
.	O

The	O
human	B-OG
population	O
is	O
first	O
partitioned	O
into	O
low	O
/	O
high	O
risk	O
groups	O
,	O
and	O
each	O
of	O
these	O
is	O
further	O
partitioned	O
into	O
those	O
that	O
never	O
participate	O
in	O
screening	O
and	O
those	O
that	O
randomly	O
participate	O
creating	O
four	O
distinct	O
human	B-OG
behaviour	O
/	O
risk	O
compartments	O
.	O

Models	O
for	O
animal	B-OG
reservoirs	O
:	O
6	O
.	O
Homogeneous	O
human	B-OG
population	O
and	O
two	O
animal	B-OG
populations	O
–	O
a	O
reservoir	O
(	O
able	O
to	O
acquire	O
and	O
transmit	O
disease	O
)	O
and	O
a	O
non	O
-	O
reservoir	O
(	O
which	O
still	O
receive	O
tsetse	B-OG
bites	O
).	O
7	O
.	O
The	O
model	O
for	O
heterogeneous	O
human	B-OG
populations	O
,	O
as	O
in	O
model	O
4	O
,	O
with	O
additional	O
animal	B-OG
reservoirs	O
.	O

In	O
all	O
further	O
discussion	O
,	O
the	O
basic	O
reproductive	O
ratio	O
,	O
R02	O
,	O
was	O
computed	O
by	O
evaluating	O
the	O
square	O
of	O
the	O
spectral	O
radius	O
of	O
the	O
next	O
generation	O
matrix	O
(	O
NGM	O
)	O
(	O
see	O
SI	O
Section	O
2	O
).	O
R02	O
was	O
chosen	O
as	O
a	O
more	O
suitable	O
metric	O
over	O
R02	O
as	O
it	O
is	O
equivalent	O
to	O
the	O
average	O
number	O
of	O
secondary	O
host	O
cases	O
generated	O
by	O
a	O
single	O
infectious	O
host	O
(	O
i	O
.	O
e	O
.	O
a	O
full	O
transmission	O
-	O
cycle	O
)	O
(	O
see	O
[	O
15	O
]).	O
R02	O
was	O
computed	O
in	O
the	O
absence	O
of	O
active	O
detection	O
and	O
treatment	O
,	O
and	O
can	O
be	O
viewed	O
as	O
a	O
measure	O
of	O
transmission	O
with	O
only	O
passive	O
detection	O
occurring	O
.	O

No	O
measure	O
was	O
given	O
after	O
active	O
screening	O
began	O
as	O
the	O
intensity	O
of	O
screening	O
varied	O
year	O
to	O
year	O
and	O
the	O
pulsed	O
nature	O
of	O
this	O
screening	O
does	O
not	O
allow	O
for	O
computation	O
using	O
the	O
NGM	O
approach	O
.	O

Model	O
fitting	O

Large	O
-	O
scale	O
active	O
detection	O
campaigns	O
in	O
the	O
region	O
under	O
consideration	O
started	O
around	O
two	O
years	O
before	O
the	O
data	O
began	O
,	O
therefore	O
1998	O
and	O
1999	O
were	O
taken	O
to	O
have	O
the	O
same	O
level	O
of	O
screening	O
as	O
2000	O
(	O
see	O
Fig	O
.	O
1	O
).	O

Prior	O
to	O
1998	O
it	O
was	O
assumed	O
that	O
disease	O
was	O
at	O
its	O
endemic	O
equilibrium	O
(	O
including	O
passive	O
detection	O
)	O
due	O
to	O
the	O
absence	O
of	O
widespread	O
intervention	O
.	O

The	O
compartmental	O
ODE	O
model	O
used	O
the	O
reported	O
percentage	O
of	O
active	O
screening	O
to	O
simulate	O
the	O
effect	O
of	O
an	O
annual	O
,	O
pulsed	O
detection	O
and	O
treatment	O
campaign	O
between	O
1998	O
and	O
2012	O
in	O
addition	O
to	O
passive	O
detection	O
and	O
treatment	O
.	O

The	O
sensitivity	O
and	O
specificity	O
of	O
the	O
active	O
diagnostic	O
algorithm	O
were	O
taken	O
to	O
be	O
91	O
%	O
and	O
99	O
.	O
9	O
%	O
respectively	O
based	O
on	O
the	O
algorithms	O
used	O
by	O
MSF	O
in	O
the	O
Republic	O
of	O
Congo	O
,	O
Sudan	O
and	O
Uganda	O
[	O
38	O
];	O
these	O
algorithms	O
involve	O
multiple	O
diagnostics	O
including	O
the	O
Card	O
Agglutination	O
test	O
for	O
trypanosomes	B-OG
on	O
whole	O
blood	O
(	O
CATT	O
-	O
WB	O
)	O
and	O
parasitological	O
examination	O
of	O
cerebral	O
spinal	O
fluid	O
from	O
lumbar	O
puncture	O
.	O

Upon	O
diagnosis	O
,	O
true	O
positives	O
in	O
the	O
model	O
were	O
successfully	O
treated	O
(	O
and	O
on	O
average	O
were	O
hospitalised	O
/	O
stayed	O
at	O
home	O
for	O
six	O
months	O
,	O
as	O
per	O
the	O
recommendation	O
[	O
26	O
]),	O
whereas	O
false	O
positives	O
remained	O
susceptible	O
.	O

Passive	O
case	O
detection	O
was	O
assumed	O
to	O
occur	O
at	O
a	O
fixed	O
rate	O
with	O
individuals	O
self	O
-	O
presenting	O
to	O
medical	O
facilities	O
after	O
developing	O
stage	O
2	O
disease	O
;	O
the	O
rate	O
was	O
chosen	O
such	O
that	O
individuals	O
remain	O
in	O
stage	O
2	O
for	O
six	O
months	O
on	O
average	O
.	O

Whilst	O
there	O
is	O
currently	O
no	O
robust	O
estimate	O
of	O
this	O
period	O
,	O
other	O
modelling	O
work	O
has	O
estimated	O
that	O
the	O
duration	O
of	O
stage	O
2	O
disease	O
is	O
nine	O
months	O
on	O
average	O
in	O
the	O
absence	O
of	O
treatment	O
[	O
39	O
].	O

In	O
addition	O
,	O
it	O
was	O
assumed	O
that	O
there	O
was	O
some	O
unknown	O
level	O
of	O
underreporting	O
of	O
cases	O
,	O
due	O
to	O
either	O
diagnosed	O
cases	O
not	O
being	O
entered	O
into	O
records	O
or	O
death	O
before	O
correct	O
diagnosis	O
(	O
autopsies	O
are	O
not	O
routinely	O
performed	O
to	O
ascertain	O
cause	O
of	O
death	O
).	O

Estimates	O
of	O
underreporting	O
for	O
HAT	B-DS
are	O
thought	O
to	O
be	O
high	O
,	O
possibly	O
in	O
excess	O
of	O
50	O
%	O
underreporting	O
[	O
37	O
,	O
40	O
,	O
41	O
].	O

The	O
parameter	O
,	O
u	O
,	O
is	O
the	O
proportion	O
of	O
passive	O
cases	O
reported	O
.	O

The	O
model	O
calculates	O
the	O
continuous	O
disease	O
dynamics	O
of	O
host	O
and	O
vector	O
populations	O
(	O
see	O
SI	O
Figure	O
S	O
.	O
1	O
)	O
and	O
outputs	O
the	O
expected	O
number	O
of	O
passively	O
detected	O
cases	O
(	O
all	O
at	O
stage	O
2	O
)	O
across	O
each	O
year	O
,	O
PM	O
(	O
i	O
),	O
and	O
the	O
expected	O
number	O
of	O
actively	O
detected	O
cases	O
(	O
both	O
stage	O
1	O
and	O
2	O
)	O
per	O
annual	O
screen	O
,	O
AM	O
(	O
i	O
)	O
(	O
see	O
SI	O
for	O
more	O
details	O
).	O

Finally	O
the	O
model	O
also	O
computes	O
the	O
actual	O
number	O
of	O
new	O
cases	O
per	O
year	O
;	O
these	O
are	O
newly	O
infected	O
individuals	O
as	O
opposed	O
to	O
newly	O
detected	O
cases	O
.	O

It	O
is	O
noted	O
that	O
the	O
number	O
of	O
detected	O
cases	O
are	O
a	O
product	O
of	O
both	O
the	O
natural	O
incidence	O
of	O
infection	B-DS
and	O
the	O
screening	O
effort	O
,	O
with	O
these	O
two	O
factors	O
difficult	O
to	O
untangle	O
in	O
reporting	O
data	O
.	O

To	O
compare	O
and	O
fit	O
the	O
models	O
to	O
the	O
number	O
of	O
reported	O
(	O
active	O
and	O
passive	O
)	O
cases	O
,	O
a	O
Metropolis	O
-	O
Hastings	O
MCMC	O
algorithm	O
was	O
used	O
to	O
calculate	O
the	O
posterior	O
mean	O
and	O
95	O
%	O
credible	O
interval	O
both	O
for	O
the	O
unknown	O
parameters	O
;	O
this	O
allows	O
the	O
inference	O
of	O
credible	O
intervals	O
for	O
the	O
incidence	O
of	O
new	O
cases	O
each	O
year	O
and	O
for	O
the	O
predicted	O
years	O
until	O
elimination	O
as	O
a	O
public	O
health	O
problem	O
.	O

The	O
fitting	O
procedure	O
estimated	O
up	O
to	O
11	O
unknown	O
parameters	O
(	O
noting	O
that	O
not	O
all	O
are	O
needed	O
in	O
all	O
cases	O
):	O
meff	O
=	O
NVpH	O
/	O
NH	O
,	O
the	O
effective	O
ratio	O
of	O
vectors	O
to	O
humans	B-OG
if	O
transmission	O
probability	O
from	O
vector	O
to	O
host	O
were	O
one	O
[	O
all	O
models	O
]	O
pV	O
,	O
the	O
transmission	O
probability	O
from	O
host	O
to	O
vector	O
[	O
all	O
models	O
]	O
ε	O
,	O
the	O
reduced	O
susceptibility	O
of	O
non	O
-	O
teneral	O
tsetse	B-OG
[	O
all	O
models	O
]	O
r	O
,	O
the	O
relative	O
risk	O
(	O
via	O
increased	O
proportion	O
of	O
bites	O
)	O
of	O
“	O
high	O
risk	O
”	O
individuals	O
compared	O
to	O
“	O
low	O
risk	O
”	O
individuals	O
[	O
models	O
2	O
,	O
4	O
,	O
5	O
,	O
7	O
]	O
k1	O
,	O
the	O
proportion	O
of	O
low	O
-	O
risk	O
,	O
participating	O
humans	B-OG
[	O
all	O
models	O
]	O
k2	O
,	O
the	O
proportion	O
of	O
high	O
-	O
risk	O
,	O
participating	O
humans	B-OG
[	O
models	O
2	O
,	O
5	O
]	O
k3	O
,	O
the	O
proportion	O
of	O
low	O
-	O
risk	O
,	O
non	O
-	O
participating	O
humans	B-OG
[	O
models	O
3	O
,	O
5	O
]	O
k4	O
,	O
the	O
proportion	O
of	O
high	O
-	O
risk	O
,	O
non	O
-	O
participating	O
humans	B-OG
[	O
models	O
4	O
,	O
5	O
,	O
7	O
]	O
kA	O
,	O
the	O
ratio	O
of	O
reservoir	O
animals	B-OG
to	O
humans	B-OG
[	O
models	O
6	O
,	O
7	O
]	O
fA	O
,	O
proportion	O
of	O
feeding	O
on	O
reservoir	O
animals	B-OG
[	O
models	O
6	O
,	O
7	O
]	O
u	O
,	O
proportion	O
of	O
passive	O
cases	O
reported	O
[	O
all	O
models	O
].	O

Other	O
model	O
parameters	O
,	O
for	O
which	O
there	O
are	O
estimates	O
available	O
,	O
were	O
kept	O
fixed	O
and	O
are	O
given	O
in	O
Table	O
1	O
.	O
Table	O
1Parameter	O
notation	O
and	O
values	O
used	O
in	O
the	O
compartmental	O
modelsNotationDescriptionValueSource	O
μ	O
H	O
Natural	O
human	B-OG
mortality	O
rate5	O
.	O
4795	O
×	O
10	O
−	O
5	O
days	O
−	O
1	O
[	O
45	O
]	O
B	O
H	O
Human	B-OG
birth	O
rate	O
μ	O
H	O
N	O
H	O
-	O
σ	O
H	O
Human	B-OG
incubation	O
rate0	O
.	O
0833	O
days	O
−	O
1	O
[	O
17	O
]	O
φ	O
H	O
Stage	O
1	O
to	O
2	O
progression	O
rate0	O
.	O
0019	O
days	O
−	O
1	O
[	O
39	O
,	O
46	O
]	O
γ	O
H	O
Treatment	O
rate	O
from	O
stage	O
20	O
.	O
006	O
days	O
−	O
1	O
Assumed	O
(	O
see	O
text	O
)	O
u	O
,	O
Proportion	O
of	O
passive	O
cases	O
reported	O
,	O
Varies	O
,	O
-	O
Frequency	O
of	O
screeningAnnual	O
-	O
Active	O
screen	O
diagnostic	O
algorithm	O
sensitivity91	O
%	O
Averaged	O
from	O
[	O
38	O
]	O
Active	O
screen	O
diagnostic	O
algorithm	O
sensitivity91	O
%	O
Averaged	O
from	O
[	O
38	O
]	O
Active	O
screen	O
diagnostic	O
algorithm	O
specificity99	O
.	O
9	O
%	O
Averaged	O
from	O
[	O
38	O
]	O
Treatment	O
compliance1Assumed	O
η	O
H	O
Pulsed	O
active	O
screening	O
ω	O
H	O
Recovery	O
rate0	O
.	O
006	O
days	O
−	O
1	O
[	O
27	O
]	O
δ	O
H	O
Disease	O
induced	O
mortality0Assumed	O
N	O
H	O
Total	O
human	B-OG
population	O
size291567	O
[	O
34	O
,	O
35	O
]	O
k	O
1	O
Proportion	O
of	O
low	O
-	O
risk	O
,	O
random	O
participation	O
peopleVaries	O
-	O
k	O
2	O
Proportion	O
of	O
low	O
-	O
risk	O
,	O
random	O
participation	O
peopleVaries	O
-	O
k	O
3	O
Proportion	O
of	O
low	O
-	O
risk	O
,	O
random	O
participation	O
peopleVaries	O
-	O
k	O
4	O
Proportion	O
of	O
low	O
-	O
risk	O
,	O
random	O
participation	O
peopleVaries	O
-	O
m	O
Relative	O
tsetse	B-OG
density	O
N	O
V	O
/	O
N	O
H	O
-	O
μ	O
V	O
Tsetse	B-OG
mortality	O
rate0	O
.	O
03	O
days	O
−	O
1	O
[	O
17	O
]	O
α	O
Tsetse	B-OG
bite	O
rate0	O
.	O
333	O
days	O
−	O
1	O
WHO	O
2013	O
σ	O
V	O
Tsetse	B-OG
incubation	O
rate0	O
.	O
034	O
days	O
−	O
1	O
[	O
47	O
,	O
48	O
]	O
p	O
V	O
Probability	O
of	O
tsetse	B-DS
infection	I-DS
per	O
single	O
infective	O
biteVaries	O
-	O
p	O
H	O
Probability	O
of	O
human	B-OG
infection	B-DS
per	O
single	O
infective	O
biteVaries	O
-	O
m	O
eff	O
Effective	O
tsetse	B-OG
density	O
=	O
mp	O
H	O
-	O
ε	O
Reduced	O
non	O
-	O
teneral	O
susceptibility	O
factorVaries	O
f	O
H	O
Proportion	O
of	O
blood	O
-	O
meals	O
on	O
humans0	O
.	O
09	O
[	O
49	O
]	O
(	O
G	O
.	O
fuscipes	O
)	O
r	O
Relative	O
bites	O
taken	O
on	O
“	O
high	O
-	O
risk	O
”	O
humans	B-OG
compared	O
to	O
“	O
low	O
-	O
risk	O
”	O
Varies	O
-	O
μ	O
A	O
Natural	O
reservoir	O
animal	B-OG
mortality	O
rate0	O
.	O
0014	O
days	O
−	O
1	O
Assumed	O
B	O
A	O
Reservoir	O
animal	B-OG
birth	O
rate	O
μ	O
A	O
N	O
A	O
-	O
σ	O
A	O
Reservoir	O
animal	B-OG
incubation	O
rate0	O
.	O
0833	O
days	O
−	O
1	O
[	O
17	O
]	O
f	O
A	O
Proportion	O
of	O
blood	O
-	O
meals	O
on	O
reservoir	O
animalsVaries	O
-	O
N	O
A	O
Reservoir	O
animal	B-OG
population	O
sizeVaries	O
-	O
p	O
A	O
Probability	O
of	O
reservoir	O
animal	B-OG
infection	B-DS
per	O
single	O
infective	O
biteVaries	O
-	O

This	O
fitting	O
procedure	O
maximised	O
the	O
binomial	O
log	O
-	O
likelihood	O
function	O
.	O

In	O
essence	O
this	O
captures	O
the	O
likelihood	O
that	O
the	O
observed	O
active	O
and	O
passive	O
cases	O
each	O
year	O
come	O
from	O
the	O
appropriate	O
random	O
sample	O
of	O
the	O
population	O
,	O
where	O
the	O
mean	O
is	O
given	O
by	O
the	O
deterministic	O
dynamics	O
(	O
SI	O
Section	O
1	O
).	O

Mathematically	O
,	O
this	O
log	O
-	O
likelihood	O
given	O
by	O
:\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}$$	O
LL	O
\	O
left	O
(\	O
left	O
.\	O
theta	O
\	O
right	O
|	O
x	O
\	O
right	O
)\	O
propto	O
\	O
log	O
\	O
left	O
(\	O
mathrm	O
{\	O
mathbb	O
{	O
P	O
}}\	O
left	O
(\	O
left	O
.	O
x	O
\	O
right	O
|\	O
theta	O
\	O
right	O
)\	O
right	O
)={\	O
displaystyle	O
{\	O
sum	O
}	O
_	O
{\	O
mathrm	O
{	O
i	O
}=	O
2000	O
}^{	O
2012	O
}}	O
ln	O
\	O
left	O
[	O
Bin	O
\	O
left	O
({	O
A	O
}	O
_D	O
(	O
i	O
);	O
z	O
(	O
i	O
){	O
N	O
}	O
_H	O
,\	O
frac	O
{	O
A_M	O
(	O
i	O
)}{	O
N_H	O
}\	O
right	O
)\	O
right	O
]+	O
ln	O
\	O
left	O
[	O
Bin	O
\	O
left	O
({	O
P	O
}	O
_D	O
(	O
i	O
);{	O
N	O
}	O
_H	O
,\	O
frac	O
{	O
P_M	O
(	O
i	O
)}{	O
N_H	O
}\	O
right	O
)\	O
right	O
]	O
$$\	O
end	O
{	O
document	O
}	O
LLθx	O
∝	O
logℙxθ	O
=∑	O
i	O
=	O
20002012lnBinADi	O
;	O
ziNH	O
,	O
AMiNH	O
+	O
lnBinPDi	O
;	O
NH	O
,	O
PMiNH	O

where	O
the	O
model	O
takes	O
parameterisation	O
θ	O
=	O
(	O
meff	O
,	O
pV	O
,	O
ε	O
,	O
r	O
,	O
k1	O
,	O
k2	O
,	O
k3	O
,	O
k4	O
,	O
kA	O
,	O
fA	O
,	O
u	O
),	O
x	O
is	O
the	O
data	O
,	O
Bin	O
(	O
m	O
;	O
n	O
,	O
p	O
)	O
binomial	O
probability	O
of	O
obtaining	O
m	O
successes	O
out	O
of	O
n	O
trails	O
with	O
probability	O
p	O
.	O

PD	O
(	O
i	O
)	O
and	O
AD	O
(	O
i	O
)	O
are	O
the	O
number	O
of	O
passive	O
/	O
active	O
cases	O
in	O
year	O
i	O
of	O
the	O
data	O
,	O
PM	O
(	O
i	O
)	O
and	O
AM	O
(	O
i	O
)	O
are	O
the	O
number	O
of	O
passive	O
/	O
active	O
cases	O
in	O
year	O
i	O
of	O
the	O
model	O
,	O
and	O
z	O
(	O
i	O
)	O
is	O
the	O
percentage	O
of	O
the	O
population	O
screened	O
in	O
year	O
i	O
.	O

The	O
competing	O
model	O
structures	O
were	O
compared	O
by	O
performing	O
deviance	O
information	O
criterion	O
DIC	O
[	O
42	O
]	O
and	O
computing	O
the	O
relative	O
likelihood	O
of	O
model	O
i	O
using	O
:	O
exp	O
((	O
DICmin	O
−	O
DICi	O
)/	O
2	O
)	O
(	O
see	O
SI	O
Section	O
S4	O
for	O
more	O
details	O
).	O

Results	O

Fitting	O
models	O
to	O
data	O

The	O
three	O
parameters	O
meff	O
,	O
pV	O
and	O
ε	O
affect	O
the	O
predicted	O
incidence	O
predominantly	O
through	O
their	O
joint	O
effect	O
on	O
the	O
basic	O
reproductive	O
ratio	O
.	O
R02	O
can	O
be	O
expressed	O
as	O
a	O
function	O
of	O
these	O
,	O
for	O
the	O
homogeneous	O
Model	O
1	O
taking	O
the	O
form	O
:\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}$$	O
{	O
R	O
}	O
_0	O
^	O
2	O
=	O
A	O
{	O
p	O
}	O
_V	O
{	O
m	O
}	O
_	O
{	O
eff	O
}\	O
left	O
(	O
1	O
+	O
B	O
\	O
varepsilon	O
\	O
right	O
)	O
$$\	O
end	O
{	O
document	O
}	O
R02	O
=	O
ApVmeff1	O
+	O
Bε	O

where	O
A	O
and	O
B	O
are	O
constants	O
given	O
by	O
the	O
known	O
parameters	O
.	O

The	O
log	O
-	O
likelihood	O
is	O
not	O
a	O
direct	O
function	O
of	O
R02	O
but	O
there	O
is	O
a	O
very	O
strong	O
dependence	O
for	O
plausible	O
ranges	O
of	O
the	O
parameters	O
,	O
and	O
the	O
maximum	O
log	O
-	O
likelihood	O
is	O
achieved	O
at	O
the	O
same	O
value	O
of	O
the	O
basic	O
reproductive	O
ratio	O
for	O
all	O
meff	O
and	O
pV	O
and	O
ε	O
(	O
see	O
SI	O
Figure	O
S	O
.	O
2	O
).	O

In	O
further	O
model	O
simulation	O
,	O
the	O
parameters	O
pV	O
and	O
ε	O
were	O
kept	O
fixed	O
at	O
0	O
.	O
065	O
and	O
0	O
.	O
05	O
respectively	O
as	O
they	O
were	O
non	O
-	O
identifiable	O
in	O
the	O
model	O
fit	O
.	O

During	O
the	O
fitting	O
procedure	O
,	O
Gaussian	O
proposals	O
were	O
made	O
for	O
R0	O
which	O
were	O
then	O
converted	O
to	O
the	O
equivalent	O
meff	O
value	O
.	O

The	O
resulting	O
best	O
fit	O
of	O
model	O
dynamics	O
between	O
1998	O
and	O
2012	O
generated	O
under	O
the	O
homogenous	O
host	O
population	O
scenario	O
(	O
Model	O
1	O
)	O
are	O
shown	O
in	O
Fig	O
.	O
3	O
.	O

This	O
simple	O
model	O
yielded	O
the	O
lowest	O
(	O
worst	O
)	O
mean	O
log	O
-	O
likelihood	O
and	O
highest	O
DIC	O
of	O
all	O
seven	O
models	O
under	O
consideration	O
(	O
see	O
Table	O
2	O
),	O
indicating	O
that	O
heterogeneity	O
in	O
host	O
population	O
(	O
s	O
)	O
is	O
needed	O
to	O
capture	O
the	O
disease	O
dynamics	O
observed	O
.	O
Fig	O
.	O
3The	O
reported	O
incidence	O
data	O
and	O
the	O
corresponding	O
Models	O
1	O
,	O
4	O
,	O
6	O
and	O
7	O
under	O
posterior	O
median	O
parameterisation	O
.	O

Green	O
lines	O
show	O
the	O
simulated	O
new	O
infection	B-DS
incidence	O
as	O
well	O
as	O
passive	O
,	O
active	O
and	O
total	O
reported	O
cases	O
under	O
each	O
model	O
.	O

N	O
.	O
B	O
Model	O
1	O
has	O
a	O
different	O
y	O
-	O
axis	O
scale	O
to	O
the	O
others	O
figuresTable	O
2Summary	O
of	O
models	O
and	O
modelling	O
comparison	O
resultsModelAssumptionsRelative	O
likelihood	O
of	O
model	O
(	O
from	O
DIC	O
)	O
NotesHumansAnimalsRandom	O
participationNon	O
-	O
participationLow	O
-	O
riskHigh	O
-	O
riskLow	O
-	O
riskHigh	O
-	O
risk1	O
✓	O
a	O
<	O
10	O
−	O
100	O
Least	O
good	O
fit2	O
✓✓≈	O
10	O
−	O
5	O
Implausible	O
parameterisation3	O
✓✓<	O
10	O
−	O
100	O
Poor	O
fit4	O
✓✓	O
0	O
.	O
955Good	O
fit5	O
✓✓✓✓	O
0	O
.	O
026No	O
improvement	O
over	O
Model	O
4	O
but	O
more	O
parameters6	O
✓	O
a	O
✓≈	O
10	O
−	O
9	O
7	O
✓✓✓	O
1Best	O
fit	O
aModels	O
1	O
and	O
6	O
have	O
homogeneous	O
risk	O
for	O
all	O
humans	B-OG
,	O
which	O
is	O
equivalent	O
to	O
all	O
humans	B-OG
being	O
“	O
low	O
-	O
risk	O
”	O
✓	O
=	O
included	O
as	O
a	O
distinct	O
host	O
category	O
in	O
the	O
model	O

All	O
heterogeneous	O
human	B-OG
models	O
(	O
Models	O
2	O
–	O
5	O
)	O
performed	O
better	O
than	O
the	O
simple	O
model	O
:	O

Model	O
2	O
(	O
high	O
/	O
low	O
risk	O
)	O
fitting	O
generated	O
very	O
high	O
values	O
of	O
r	O
,	O
the	O
relative	O
number	O
of	O
bites	O
on	O
high	O
-	O
risk	O
individuals	O
compared	O
to	O
low	O
-	O
risk	O
,	O
and	O
very	O
small	O
k2	O
,	O
the	O
proportion	O
of	O
the	O
population	O
in	O
the	O
high	O
-	O
risk	O
group	O
,	O
indicating	O
extreme	O
levels	O
of	O
heterogeneity	O
that	O
are	O
implausible	O
.	O

Model	O
3	O
(	O
random	O
/	O
non	O
participation	O
)	O
performed	O
less	O
well	O
than	O
Model	O
2	O
and	O
only	O
slightly	O
better	O
than	O
the	O
simple	O
model	O
.	O

Model	O
4	O
(	O
low	O
-	O
risk	O
random	O
/	O
high	O
-	O
risk	O
non	O
-	O
participation	O
)	O
was	O
the	O
best	O
fitting	O
heterogeneous	O
human	B-OG
model	O
with	O
realistic	O
parameterisation	O
.	O

It	O
was	O
calculated	O
that	O
high	O
-	O
risk	O
individuals	O
were	O
bitten	O
r	O
=	O
6	O
.	O
6	O
times	O
more	O
and	O
made	O
up	O
k4	O
=	O
7	O
.	O
6	O
%	O
of	O
the	O
human	B-OG
population	O
(	O
see	O
SI	O
Additional	O
file	O
1	O
:	O
Table	O
S1	O
).	O

This	O
case	O
is	O
also	O
shown	O
in	O
Fig	O
.	O
3	O
;	O
the	O
generated	O
incidence	O
from	O
this	O
model	O
is	O
a	O
much	O
better	O
fit	O
than	O
under	O
the	O
basic	O
homogeneous	O
assumption	O
(	O
Model	O
1	O
).	O

The	O
parameters	O
obtained	O
for	O
Model	O
5	O
converge	O
to	O
values	O
close	O
to	O
those	O
of	O
Model	O
4	O
,	O
which	O
is	O
a	O
sub	O
-	O
model	O
of	O
this	O
more	O
inclusive	O
formulation	O
.	O

Given	O
that	O
Model	O
5	O
does	O
not	O
generate	O
a	O
substantial	O
improvement	O
in	O
the	O
likelihood	O
,	O
but	O
requires	O
more	O
parameters	O
,	O
it	O
has	O
a	O
higher	O
DIC	O
.	O

This	O
suggests	O
that	O
Model	O
4	O
is	O
the	O
most	O
plausible	O
human	B-OG
-	O
only	O
model	O
that	O
conforms	O
with	O
our	O
understanding	O
of	O
the	O
biology	O
of	O
HAT	B-DS
.	O

Again	O
,	O
the	O
heterogeneity	O
introduced	O
by	O
allowing	O
for	O
two	O
host	O
species	O
(	O
humans	B-OG
and	O
reservoir	O
animals	B-OG
,	O
Model	O
6	O
),	O
significantly	O
improved	O
model	O
fit	O
over	O
the	O
homogeneous	O
human	B-OG
model	O
(	O
Model	O
1	O
),	O
however	O
Model	O
6	O
yielded	O
a	O
less	O
good	O
fit	O
than	O
Model	O
4	O
.	O

Results	O
for	O
Model	O
6	O
are	O
shown	O
as	O
it	O
forms	O
a	O
base	O
-	O
case	O
for	O
the	O
inclusion	O
of	O
reservoir	O
animals	B-OG
.	O

Model	O
7	O
(	O
low	O
-	O
risk	O
random	O
/	O
high	O
-	O
risk	O
non	O
-	O
participation	O
and	O
animals	B-OG
;	O
i	O
.	O
e	O
.	O
Model	O
4	O
plus	O
reservoir	O
animals	B-OG
)	O
generates	O
a	O
slightly	O
improved	O
likelihood	O
over	O
Model	O
4	O
when	O
fitted	O
to	O
the	O
data	O
.	O

The	O
parameters	O
of	O
Model	O
7	O
suggest	O
that	O
an	O
animal	B-OG
reservoir	O
may	O
play	O
a	O
small	O
but	O
significant	O
role	O
in	O
transmission	O
,	O
but	O
this	O
may	O
not	O
be	O
necessary	O
to	O
explain	O
the	O
data	O
given	O
that	O
Model	O
4	O
fits	O
almost	O
as	O
well	O
.	O

Figure	O
3	O
shows	O
best	O
fits	O
for	O
the	O
four	O
models	O
variants	O
(	O
Models	O
1	O
,	O
4	O
,	O
6	O
and	O
7	O
)	O
and	O
the	O
reported	O
incidence	O
from	O
the	O
WHO	O
HAT	B-DS
Atlas	O
.	O

It	O
is	O
seen	O
that	O
Model	O
1	O
is	O
a	O
poor	O
fit	O
to	O
the	O
data	O
(	O
N	O
.	O
B	O
.	O
the	O
y	O
-	O
axis	O
range	O
is	O
greater	O
than	O
the	O
data	O
or	O
other	O
models	O
).	O

Model	O
4	O
is	O
quantitatively	O
a	O
much	O
better	O
fit	O
and	O
generates	O
the	O
distinctive	O
peak	O
in	O
2009	O
and	O
dip	O
in	O
2011	O
consistent	O
with	O
the	O
data	O
.	O

Models	O
6	O
and	O
7	O
qualitatively	O
display	O
the	O
patterns	O
seen	O
in	O
observed	O
cases	O
,	O
however	O
Model	O
7	O
produces	O
a	O
better	O
fit	O
than	O
Model	O
6	O
.	O

It	O
is	O
concluded	O
that	O
heterogeneity	O
within	O
the	O
human	B-OG
population	O
is	O
needed	O
to	O
generate	O
the	O
observed	O
cases	O
and	O
fitting	O
suggests	O
that	O
individuals	O
who	O
are	O
more	O
exposed	O
to	O
tsetse	B-OG
bites	O
are	O
also	O
not	O
participating	O
during	O
active	O
screening	O
campaigns	O
.	O

Animal	B-OG
reservoirs	O
alone	O
(	O
Model	O
6	O
)	O
seem	O
less	O
able	O
to	O
capture	O
the	O
disease	O
dynamics	O
than	O
heterogeneous	O
human	B-OG
populations	O
(	O
Model	O
4	O
),	O
however	O
,	O
this	O
does	O
not	O
exclude	O
the	O
possibility	O
of	O
both	O
heterogeneity	O
in	O
humans	B-OG
and	O
an	O
animal	B-OG
reservoir	O
(	O
Model	O
7	O
).	O

Further	O
simulations	O
(	O
results	O
not	O
shown	O
here	O
),	O
demonstrated	O
that	O
the	O
results	O
for	O
model	O
choice	O
are	O
maintained	O
for	O
other	O
biologically	O
plausible	O
choices	O
for	O
the	O
parameters	O
fH	O
,	O
the	O
proportion	O
of	O
bites	O
on	O
humans	B-OG
(	O
fH	O
=	O
0	O
.	O
4	O
),	O
and	O
μA	O
,	O
the	O
animal	B-OG
death	O
rate	O
(	O
μA	O
=	O
0	O
.	O
014	O
day	O
−	O
1	O
).	O

In	O
these	O
simulations	O
,	O
the	O
relative	O
likelihoods	O
are	O
similar	O
to	O
those	O
shown	O
in	O
Table	O
2	O
.	O

Fitting	O
yielded	O
an	O
altered	O
range	O
of	O
possible	O
values	O
of	O
meff	O
,	O
kA	O
and	O
fA	O
,	O
however	O
there	O
is	O
currently	O
no	O
means	O
of	O
discerning	O
the	O
most	O
realistic	O
ranges	O
without	O
improved	O
field	O
or	O
laboratory	O
estimates	O
for	O
some	O
of	O
the	O
uncertain	O
parameter	O
values	O
.	O

Predicting	O
forwards	O

To	O
establish	O
the	O
long	O
-	O
term	O
impact	O
of	O
current	O
active	O
screening	O
in	O
the	O
area	O
,	O
the	O
model	O
was	O
projected	O
forward	O
from	O
2012	O
using	O
either	O
the	O
mean	O
or	O
maximum	O
level	O
of	O
screening	O
observed	O
previously	O
(	O
i	O
.	O
e	O
.	O
29	O
.	O
9	O
%	O
or	O
53	O
.	O
6	O
%,	O
respectively	O
).	O

Under	O
these	O
two	O
different	O
scenarios	O
the	O
predicted	O
time	O
to	O
elimination	O
(<	O
1	O
case	O
per	O
10	O
,	O
000	O
people	O
)	O
was	O
computed	O
for	O
the	O
Models	O
1	O
,	O
4	O
,	O
6	O
and	O
7	O
(	O
Fig	O
.	O
4	O
).	O

This	O
elimination	O
year	O
is	O
defined	O
here	O
to	O
be	O
the	O
first	O
year	O
in	O
which	O
the	O
incidence	O
of	O
new	O
infections	B-DS
falls	O
below	O
1	O
in	O
10	O
000	O
(	O
where	O
the	O
green	O
lines	O
cross	O
).	O

These	O
predicted	O
elimination	O
years	O
and	O
the	O
basic	O
reproductive	O
ratio	O
,	O
R02	O
,	O
are	O
given	O
in	O
Table	O
3	O
along	O
with	O
their	O
95	O
%	O
credible	O
intervals	O
.	O
Fig	O
.	O
4Projected	O
incidence	O
for	O
HAT	B-DS
beginning	O
in	O
2013	O
for	O
Models	O
1	O
,	O
4	O
,	O
6	O
and	O
7	O
under	O
posterior	O
median	O
parameterisation	O
.	O

Stars	O
show	O
the	O
simulated	O
years	O
of	O
elimination	O
as	O
a	O
public	O
health	O
problem	O
under	O
either	O
(	O
i	O
)	O
continuing	O
with	O
the	O
mean	O
level	O
of	O
screening	O
or	O
(	O
ii	O
)	O
continuing	O
with	O
the	O
maximum	O
level	O
of	O
screening	O
achieved	O
between	O
2000	O
and	O
2012	O
.	O

The	O
imperfect	O
specificity	O
of	O
the	O
diagnostic	O
algorithm	O
used	O
in	O
active	O
screening	O
results	O
in	O
persistent	O
reporting	O
of	O
actively	O
detected	O
cases	O
even	O
after	O
elimination	O
has	O
been	O
achievedTable	O
3For	O
each	O
biologically	O
feasible	O
model	O
,	O
this	O
table	O
gives	O
the	O
mean	O
R	O
02	O
values	O
in	O
the	O
absence	O
of	O
annual	O
active	O
screening	O
as	O
well	O
as	O
the	O
predicted	O
elimination	O
years	O
under	O
either	O
mean	O
screening	O
levels	O
or	O
maximum	O
screening	O
levels	O
.	O

95	O
%	O
credible	O
intervals	O
are	O
given	O
in	O
bracketsModelPre	O
-	O
active	O
screen	O
R	O
02	O
Elimination	O
as	O
a	O
public	O
health	O
problem	O
yearMean	O
screenMax	O
screen11	O
.	O
024	O
[	O
1	O
.	O
023	O
,	O
1	O
.	O
025	O
]	O
2014	O
[	O
2014	O
,	O
2015	O
]	O
2013	O
[	O
2013	O
,	O
2015	O
]	O
41	O
.	O
046	O
[	O
1	O
.	O
038	O
,	O
1	O
.	O
056	O
]	O
2140	O
[	O
2103	O
,	O
2199	O
]	O
2074	O
[	O
2060	O
,	O
2092	O
]	O
61	O
.	O
005	O
[	O
1	O
.	O
005	O
,	O
1	O
.	O
005	O
]	O
2077	O
[	O
2072	O
,	O
2101	O
]	O
2059	O
[	O
2050	O
,	O
2069	O
]	O
71	O
.	O
040	O
[	O
1	O
.	O
032	O
,	O
1	O
.	O
048	O
]	O
2124	O
[	O
2098	O
,	O
2176	O
]	O
2072	O
[	O
2059	O
,	O
2091	O
]	O

Under	O
the	O
homogeneous	O
model	O
,	O
the	O
target	O
should	O
have	O
already	O
been	O
reached	O
as	O
of	O
2014	O
,	O
assuming	O
average	O
screening	O
levels	O
since	O
2012	O
(	O
Fig	O
.	O
4	O
).	O

However	O
,	O
as	O
this	O
model	O
variant	O
is	O
a	O
poor	O
fit	O
for	O
the	O
data	O
,	O
this	O
is	O
deemed	O
to	O
be	O
improbable	O
.	O

With	O
heterogeneity	O
in	O
humans	B-OG
,	O
the	O
time	O
to	O
elimination	O
becomes	O
longer	O
,	O
particularly	O
if	O
only	O
mean	O
screening	O
levels	O
are	O
achieved	O
each	O
year	O
.	O

In	O
the	O
fitted	O
model	O
without	O
animal	B-OG
reservoirs	O
(	O
Model	O
4	O
),	O
even	O
maximum	O
screening	O
does	O
not	O
achieve	O
WHO	O
2020	O
goals	O
,	O
with	O
elimination	O
as	O
a	O
public	O
health	O
problem	O
being	O
reached	O
in	O
2074	O
(	O
95	O
%	O
CI	O
:	O
2060	O
–	O
2092	O
).	O

Assuming	O
mean	O
screening	O
substantially	O
delays	O
the	O
predicted	O
elimination	O
date	O
for	O
all	O
models	O
(	O
see	O
Table	O
3	O
).	O

Including	O
an	O
animal	B-OG
reservoir	O
considerably	O
increases	O
the	O
time	O
to	O
elimination	O
with	O
a	O
homogeneous	O
human	B-OG
population	O
(	O
i	O
.	O
e	O
.	O
Model	O
1	O
predicts	O
elimination	O
by	O
2013	O
while	O
Model	O
6	O
predicts	O
2059	O
).	O

However	O
the	O
difference	O
in	O
elimination	O
years	O
for	O
Models	O
4	O
and	O
7	O
is	O
small	O
.	O

A	O
key	O
observation	O
is	O
that	O
the	O
actual	O
incidence	O
of	O
new	O
infections	B-DS
is	O
very	O
different	O
from	O
the	O
reported	O
case	O
incidence	O
;	O
in	O
particular	O
the	O
year	O
in	O
which	O
the	O
incidence	O
of	O
new	O
infections	B-DS
falls	O
below	O
1	O
per	O
10	O
,	O
000	O
is	O
not	O
the	O
same	O
as	O
when	O
the	O
reported	O
incidence	O
is	O
1	O
per	O
10	O
,	O
000	O
.	O

The	O
passive	O
incidence	O
is	O
expected	O
to	O
cross	O
this	O
threshold	O
by	O
as	O
much	O
as	O
74	O
years	O
before	O
the	O
new	O
infection	B-DS
incidence	O
crosses	O
the	O
same	O
threshold	O
(	O
Model	O
4	O
,	O
mean	O
screening	O
).	O

This	O
is	O
due	O
largely	O
to	O
high	O
levels	O
of	O
underreporting	O
of	O
passive	O
cases	O
,	O
with	O
an	O
estimated	O
reporting	O
rate	O
of	O
approximately	O
26	O
%	O
(	O
see	O
Additional	O
file	O
1	O
:	O
Table	O
S2	O
).	O

In	O
contrast	O
,	O
the	O
long	O
-	O
term	O
active	O
case	O
incidence	O
is	O
dominated	O
by	O
the	O
specificity	O
of	O
the	O
diagnostic	O
algorithm	O
and	O
the	O
level	O
of	O
active	O
screening	O
.	O

Moving	O
forwards	O
it	O
is	O
crucial	O
to	O
define	O
precisely	O
what	O
“	O
incidence	O
”	O
means	O
in	O
terms	O
of	O
elimination	O
milestones	O
and	O
to	O
ensure	O
that	O
the	O
number	O
of	O
cases	O
continues	O
to	O
decline	O
following	O
elimination	O
as	O
a	O
public	O
health	O
problem	O
.	O

Discussion	O

Implications	O
for	O
2020	O
goals	O

Model	O
fitting	O
indicates	O
that	O
the	O
past	O
efforts	O
of	O
active	O
detection	O
and	O
treatment	O
in	O
Yasa	O
-	O
Bonga	O
and	O
Mosango	O
health	O
zones	O
of	O
the	O
DRC	O
have	O
halved	O
(	O
52	O
-	O
53	O
%	O
reduction	O
)	O
the	O
number	O
of	O
new	O
infections	B-DS
over	O
a	O
15	O
-	O
year	O
period	O
.	O

Although	O
this	O
figure	O
is	O
lower	O
than	O
the	O
63	O
%	O
reduction	O
in	O
reported	O
cases	O
across	O
these	O
health	O
zones	O
between	O
2000	O
–	O
2012	O
,	O
this	O
difference	O
is	O
due	O
,	O
in	O
part	O
,	O
to	O
the	O
level	O
and	O
timing	O
of	O
screening	O
which	O
impact	O
upon	O
reporting	O
in	O
addition	O
to	O
the	O
impact	O
of	O
underreporting	O
.	O

Despite	O
this	O
success	O
however	O
,	O
these	O
simulations	O
suggest	O
that	O
we	O
are	O
unlikely	O
to	O
meet	O
the	O
elimination	O
goal	O
in	O
these	O
health	O
zones	O
by	O
2020	O
if	O
current	O
strategies	O
continue	O
unchanged	O
;	O
this	O
includes	O
sustaining	O
the	O
highest	O
level	O
(	O
53	O
.	O
1	O
%)	O
of	O
yearly	O
active	O
screening	O
.	O

The	O
results	O
of	O
fitting	O
multiple	O
model	O
formulations	O
to	O
the	O
data	O
predicts	O
that	O
with	O
the	O
highest	O
levels	O
of	O
screening	O
the	O
elimination	O
target	O
will	O
be	O
met	O
between	O
2059	O
and	O
2092	O
.	O

If	O
future	O
screening	O
follows	O
the	O
mean	O
(	O
29	O
.	O
6	O
%)	O
then	O
the	O
predicted	O
elimination	O
year	O
is	O
increased	O
,	O
lying	O
between	O
2098	O
and	O
2199	O
.	O

Whilst	O
there	O
has	O
been	O
almost	O
80	O
%	O
reduction	O
in	O
reported	O
cases	O
for	O
the	O
whole	O
DRC	O
between	O
1998	O
–	O
2012	O
[	O
7	O
],	O
Bandundu	O
province	O
of	O
DRC	O
remains	O
one	O
of	O
the	O
regions	O
with	O
the	O
highest	O
HAT	B-DS
burden	O
globally	O
,	O
and	O
it	O
is	O
therefore	O
anticipated	O
to	O
be	O
one	O
of	O
the	O
toughest	O
areas	O
in	O
which	O
to	O
meet	O
this	O
target	O
.	O

This	O
article	O
presents	O
a	O
suite	O
of	O
models	O
focussed	O
on	O
elucidating	O
the	O
underlying	O
transmission	O
pathways	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
gambiense	I-OG
.	O

To	O
compare	O
and	O
fit	O
competing	O
model	O
structures	O
,	O
certain	O
aspects	O
which	O
may	O
impact	O
transmission	O
of	O
this	O
disease	O
were	O
not	O
included	O
and	O
may	O
account	O
for	O
some	O
of	O
the	O
differences	O
seen	O
between	O
the	O
model	O
output	O
and	O
data	O
.	O

We	O
have	O
implicitly	O
assumed	O
spatial	O
homogeneity	O
,	O
such	O
that	O
all	O
locations	O
within	O
the	O
health	O
zones	O
experience	O
the	O
same	O
level	O
of	O
screening	O
and	O
have	O
the	O
same	O
underlying	O
epidemiological	O
risks	O
.	O

Spatial	O
heterogeneity	O
may	O
account	O
for	O
the	O
larger	O
peak	O
in	O
active	O
incidence	O
seen	O
in	O
2009	O
if	O
the	O
increase	O
in	O
screening	O
was	O
achieved	O
through	O
screening	O
new	O
areas	O
rather	O
than	O
increasing	O
the	O
proportion	O
screened	O
in	O
towns	O
that	O
previously	O
participated	O
.	O

Throughout	O
we	O
have	O
treated	O
the	O
data	O
from	O
these	O
two	O
health	O
zones	O
(	O
which	O
cover	O
6160	O
km2	O
[	O
34	O
,	O
35	O
])	O
as	O
a	O
single	O
population	O
,	O
whereas	O
in	O
reality	O
it	O
is	O
comprised	O
of	O
multiple	O
towns	O
and	O
villages	O
.	O

This	O
spatial	O
heterogeneity	O
is	O
computationally	O
intensive	O
to	O
capture	O
,	O
but	O
may	O
have	O
an	O
effect	O
on	O
our	O
inferred	O
parameters	O
and	O
hence	O
our	O
long	O
-	O
term	O
predictions	O
.	O

However	O
,	O
given	O
that	O
many	O
regions	O
follow	O
the	O
aggregate	O
pattern	O
,	O
we	O
do	O
not	O
expect	O
a	O
qualitative	O
change	O
to	O
our	O
results	O
.	O

Likewise	O
,	O
other	O
spatial	O
differences	O
in	O
the	O
human	B-OG
population	O
and	O
tsetse	B-OG
habitat	O
were	O
not	O
included	O
and	O
could	O
affect	O
model	O
outcomes	O
.	O

It	O
was	O
also	O
assumed	O
that	O
the	O
passive	O
detection	O
rate	O
and	O
reporting	O
levels	O
were	O
unaffected	O
by	O
active	O
screening	O
campaigns	O
,	O
however	O
it	O
may	O
be	O
that	O
passive	O
detection	O
becomes	O
greater	O
with	O
the	O
increase	O
in	O
awareness	O
of	O
HAT	B-DS
in	O
the	O
area	O
.	O

The	O
model	O
made	O
use	O
of	O
constant	O
human	B-OG
population	O
sizes	O
across	O
the	O
health	O
zones	O
,	O
as	O
very	O
limited	O
demographic	O
data	O
for	O
these	O
regions	O
were	O
available	O
.	O

It	O
is	O
believed	O
that	O
small	O
variation	O
in	O
total	O
population	O
size	O
,	O
for	O
example	O
a	O
low	O
-	O
level	O
population	O
growth	O
rate	O
,	O
would	O
not	O
qualitatively	O
alter	O
the	O
results	O
,	O
however	O
longitudinal	O
estimates	O
of	O
the	O
demography	O
of	O
the	O
population	O
at	O
a	O
health	O
zone	O
level	O
would	O
strengthen	O
future	O
modelling	O
by	O
providing	O
reliable	O
values	O
for	O
the	O
population	O
sizes	O
over	O
time	O
.	O

The	O
model	O
indicates	O
that	O
underreporting	O
of	O
HAT	B-DS
is	O
high	O
(	O
possibly	O
as	O
much	O
as	O
77	O
%	O
underreporting	O
),	O
which	O
is	O
in	O
line	O
with	O
values	O
suggested	O
in	O
the	O
literature	O
[	O
40	O
].	O

Although	O
it	O
is	O
not	O
possible	O
to	O
determine	O
whether	O
this	O
is	O
due	O
to	O
under	O
-	O
detection	O
of	O
disease	O
and	O
a	O
subsequent	O
lack	O
of	O
identification	O
of	O
cause	O
of	O
death	O
,	O
or	O
errors	O
in	O
data	O
reporting	O
.	O

Additional	O
data	O
,	O
such	O
as	O
testing	O
for	O
HAT	B-DS
infection	I-DS
posthumously	O
,	O
would	O
provide	O
future	O
models	O
with	O
more	O
robust	O
estimates	O
for	O
this	O
value	O
.	O

Unfortunately	O
there	O
are	O
currently	O
no	O
published	O
estimates	O
within	O
the	O
DRC	O
for	O
tsetse	B-OG
or	O
animal	B-OG
T	B-DS
.	I-DS
b	I-DS
.	I-DS
gambiense	I-DS
infection	I-DS
prevalences	O
.	O

Whilst	O
the	O
model	O
generates	O
extremely	O
low	O
tsetse	B-OG
prevalences	O
,	O
in	O
the	O
order	O
of	O
10	O
−	O
4	O
to	O
10	O
−	O
5	O
,	O
limited	O
data	O
for	O
other	O
HAT	B-DS
endemic	O
countries	O
has	O
indicated	O
that	O
infection	B-DS
levels	O
of	O
T	B-OG
.	I-OG
b	I-OG
.	I-OG
gambiense	I-OG
in	O
tsetse	B-OG
were	O
found	O
to	O
be	O
at	O
similarly	O
low	O
levels	O
,	O
of	O
the	O
order	O
10	O
−	O
4	O
[	O
4	O
].	O

New	O
data	O
on	O
infection	B-DS
in	O
tsetse	B-OG
and	O
/	O
or	O
animals	B-OG
would	O
enable	O
model	O
validation	O
and	O
refinement	O
.	O

There	O
remain	O
substantial	O
uncertainties	O
in	O
many	O
components	O
of	O
HAT	B-DS
transmission	O
including	O
relative	O
risk	O
of	O
different	O
groups	O
of	O
people	O
,	O
vector	O
competence	O
and	O
the	O
ratio	O
of	O
tsetse	B-OG
to	O
hosts	O
.	O

Another	O
modelling	O
study	O
which	O
was	O
fitted	O
to	O
data	O
from	O
Guinea	O
[	O
ref	O
-	O
50	O
(	O
Pandey	O
)]	O
also	O
concluded	O
that	O
an	O
animal	B-OG
reservoir	O
cannot	O
be	O
ruled	O
out	O
.	O

Gathering	O
empirical	O
data	O
will	O
be	O
vital	O
to	O
improve	O
and	O
refine	O
models	O
and	O
their	O
predictions	O
.	O

Future	O
for	O
Gambian	O
HAT	B-DS

This	O
article	O
presents	O
results	O
based	O
on	O
defining	O
“	O
elimination	O
as	O
a	O
public	O
health	O
problem	O
”	O
as	O
the	O
point	O
where	O
the	O
number	O
of	O
new	O
infections	B-DS
falls	O
below	O
1	O
per	O
10	O
,	O
000	O
per	O
year	O
.	O

In	O
practice	O
,	O
it	O
is	O
hard	O
to	O
determine	O
when	O
this	O
milestone	O
is	O
achieved	O
based	O
on	O
active	O
and	O
/	O
or	O
passive	O
case	O
reporting	O
.	O

Passive	O
case	O
incidence	O
will	O
drop	O
below	O
this	O
threshold	O
before	O
this	O
target	O
is	O
actually	O
met	O
and	O
is	O
contingent	O
upon	O
the	O
level	O
of	O
underreporting	O
.	O

The	O
number	O
of	O
cases	O
identified	O
by	O
active	O
case	O
detection	O
will	O
be	O
highly	O
dependent	O
upon	O
specificity	O
and	O
screening	O
levels	O
especially	O
towards	O
the	O
“	O
end	O
-	O
game	O
”	O
stages	O
of	O
elimination	O
.	O

Without	O
introducing	O
more	O
specific	O
diagnostics	O
or	O
diagnostic	O
algorithms	O
,	O
it	O
is	O
possible	O
that	O
reported	O
active	O
incidence	O
may	O
never	O
fall	O
below	O
the	O
1	O
per	O
10	O
,	O
000	O
threshold	O
due	O
to	O
false	O
positives	O
.	O

Mechanistic	O
models	O
can	O
help	O
determine	O
the	O
incidence	O
of	O
new	O
infections	B-DS
and	O
so	O
,	O
in	O
the	O
future	O
,	O
could	O
provide	O
guidance	O
as	O
to	O
when	O
controls	O
may	O
be	O
lifted	O
without	O
recrudescence	O
occurring	O
.	O

Modelling	O
indicates	O
that	O
heterogeneities	O
in	O
the	O
human	B-OG
population	O
play	O
an	O
important	O
role	O
in	O
recent	O
disease	O
dynamics	O
.	O

This	O
points	O
towards	O
ways	O
of	O
improving	O
current	O
active	O
detection	O
such	O
as	O
ensuring	O
more	O
of	O
the	O
population	O
is	O
screened	O
,	O
in	O
particular	O
those	O
who	O
have	O
typically	O
not	O
presented	O
at	O
or	O
those	O
who	O
are	O
high	O
-	O
risk	O
/	O
or	O
those	O
who	O
are	O
high	O
-	O
risk	O
.	O

These	O
results	O
are	O
in	O
line	O
with	O
the	O
theoretical	O
modelling	O
investigation	O
by	O
Stone	O
and	O
Chitnis	O
[	O
ref	O
-	O
51	O
]	O
which	O
suggests	O
targeting	O
high	O
-	O
risk	O
individuals	O
in	O
screening	O
is	O
necessary	O
(	O
and	O
may	O
,	O
in	O
some	O
cases	O
,	O
be	O
sufficient	O
)	O
to	O
disrupt	O
transmission	O
.	O

Model	O
results	O
here	O
suggest	O
that	O
around	O
8	O
-	O
9	O
%	O
of	O
the	O
human	B-OG
population	O
are	O
both	O
more	O
exposed	O
to	O
the	O
bites	O
of	O
tsetse	B-OG
and	O
never	O
participate	O
in	O
active	O
screening	O
;	O
this	O
estimate	O
is	O
generated	O
by	O
model	O
fitting	O
rather	O
than	O
social	O
quantification	O
.	O

Moving	O
forwards	O
it	O
would	O
be	O
beneficial	O
to	O
find	O
suitable	O
methods	O
to	O
identify	O
such	O
individuals	O
so	O
that	O
they	O
may	O
be	O
targeted	O
during	O
screening	O
.	O

Additionally	O
,	O
new	O
improvements	O
in	O
drugs	O
for	O
the	O
future	O
treatment	O
of	O
HAT	B-DS
[	O
9	O
]	O
may	O
help	O
improve	O
participation	O
in	O
screening	O
,	O
for	O
example	O
if	O
new	O
drugs	O
could	O
be	O
administered	O
on	O
an	O
out	O
-	O
patient	O
basis	O
,	O
or	O
if	O
the	O
rest	O
period	O
following	O
treatment	O
were	O
reduced	O
.	O

These	O
two	O
health	O
zones	O
have	O
not	O
employed	O
vector	O
control	O
as	O
part	O
of	O
their	O
intervention	O
programme	O
,	O
and	O
whilst	O
promising	O
new	O
methods	O
of	O
tsetse	B-OG
control	O
are	O
emerging	O
(	O
e	O
.	O
g	O
.	O
use	O
of	O
tiny	O
targets	O
[	O
43	O
,	O
44	O
])	O
their	O
use	O
was	O
not	O
modelled	O
here	O
.	O

Tsetse	B-OG
control	O
through	O
tiny	O
targets	O
has	O
not	O
yet	O
been	O
implemented	O
at	O
scale	O
in	O
this	O
area	O
but	O
has	O
shown	O
great	O
potential	O
at	O
significantly	O
reducing	O
tsetse	B-OG
densities	O
(	O
up	O
to	O
90	O
%)	O
over	O
a	O
large	O
area	O
[	O
43	O
],	O
offering	O
a	O
promising	O
complementary	O
strategy	O
and	O
are	O
currently	O
being	O
trialled	O
in	O
Yasa	O
-	O
Bonga	O
.	O
In	O
another	O
modelling	O
study	O
,	O
Pandey	O
et	O
al	O
[	O
ref	O
-	O
50	O
]	O
find	O
that	O
by	O
using	O
a	O
two	O
-	O
pronged	O
strategy	O
,	O
combining	O
active	O
screening	O
and	O
vector	O
control	O
,	O
the	O
Boffa	O
focus	O
in	O
Guinea	O
is	O
likely	O
to	O
meet	O
the	O
2020	O
elimination	O
target	O
.	O

In	O
the	O
work	O
presented	O
here	O
,	O
it	O
is	O
unclear	O
from	O
fitting	O
to	O
the	O
DRC	O
data	O
,	O
whether	O
animals	B-OG
play	O
an	O
active	O
role	O
in	O
transmission	O
in	O
this	O
area	O
,	O
however	O
tsetse	B-OG
control	O
provides	O
an	O
intervention	O
that	O
circumvents	O
heterogeneities	O
in	O
the	O
human	B-OG
(	O
and	O
possible	O
animal	B-OG
reservoir	O
)	O
population	O
(	O
s	O
)	O
by	O
reducing	O
biting	O
pressure	O
towards	O
all	O
hosts	O
.	O

Since	O
it	O
is	O
a	O
novel	O
strategy	O
to	O
this	O
area	O
,	O
the	O
quantitative	O
impact	O
of	O
vector	O
control	O
on	O
disease	O
cannot	O
be	O
directly	O
assessed	O
,	O
however	O
by	O
utilising	O
and	O
fitting	O
to	O
data	O
sets	O
(	O
both	O
human	B-OG
case	O
data	O
and	O
vector	O
data	O
)	O
from	O
regions	O
with	O
existing	O
vector	O
control	O
(	O
such	O
as	O
Uganda	O
and	O
Guinea	O
),	O
appropriate	O
extensions	O
to	O
the	O
existing	O
model	O
can	O
be	O
made	O
and	O
used	O
to	O
extrapolate	O
into	O
regions	O
,	O
like	O
Yasa	O
-	O
Bonga	O
and	O
Mosango	O
,	O
where	O
pre	O
-	O
vector	O
control	O
dynamics	O
are	O
known	O
[	O
27	O
].	O

Conclusions	O

A	O
mechanistic	O
modelling	O
framework	O
for	O
Gambian	O
HAT	B-DS
was	O
developed	O
to	O
assess	O
the	O
success	O
of	O
on	O
-	O
going	O
active	O
detection	O
and	O
treatment	O
in	O
Bandundu	O
Province	O
of	O
the	O
DRC	O
and	O
predict	O
the	O
time	O
until	O
HAT	B-DS
will	O
be	O
eliminated	O
as	O
a	O
public	O
health	O
problem	O
in	O
the	O
region	O
.	O

It	O
was	O
concluded	O
that	O
active	O
detection	O
campaigns	O
in	O
this	O
area	O
are	O
responsible	O
for	O
halving	O
the	O
number	O
of	O
new	O
infections	B-DS
between	O
1998	O
and	O
2012	O
,	O
however	O
this	O
high	O
-	O
endemicity	O
region	O
is	O
unlikely	O
to	O
achieve	O
the	O
WHO	O
goal	O
of	O
1	O
case	O
per	O
10	O
,	O
000	O
people	O
per	O
year	O
by	O
2020	O
.	O

The	O
suite	O
of	O
models	O
predict	O
that	O
this	O
elimination	O
target	O
will	O
only	O
be	O
reached	O
by	O
2059	O
–	O
2092	O
,	O
even	O
if	O
the	O
highest	O
levels	O
of	O
screening	O
achieved	O
between	O
2000	O
and	O
2012	O
(	O
53	O
.	O
1	O
%)	O
continue	O
every	O
year	O
.	O

This	O
suggests	O
that	O
additional	O
strategies	O
such	O
as	O
vector	O
control	O
and	O
/	O
or	O
improved	O
screening	O
of	O
the	O
human	B-OG
population	O
are	O
required	O
to	O
accelerate	O
progress	O
against	O
Gambian	O
HAT	B-DS
.	O

Supplementary	O
information	O
.	O
Model	O
equations	O
and	O
statistical	O
methodology	O
.	O

(	O
M	O
19	O
kb	O
)	O

Model	O
code	O
.	O
Matlab	O
code	O
for	O
ODE	O
model	O
simulation	O
.	O

Competing	O
interests	O

The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

Authors	O
’	O
contributions	O

KSR	O
and	O
MJK	O
developed	O
the	O
mathematical	O
model	O
,	O
wrote	O
code	O
,	O
performed	O
simulations	O
,	O
analysed	O
results	O
and	O
drafted	O
the	O
manuscript	O
.	O

SJT	O
provided	O
essential	O
biological	O
knowledge	O
during	O
model	O
development	O
,	O
data	O
interpretation	O
and	O
analysis	O
of	O
model	O
results	O
and	O
drafted	O
the	O
manuscript	O
.	O

CL	O
provided	O
knowledge	O
on	O
management	O
of	O
HAT	B-DS
in	O
DRC	O
and	O
drafted	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

